Ask AI
ProCE Banner Activity

Integrating Timely CKM Care in Primary Care: From Risk Assessment to GDMT Initiation

Clinical Thought

Cardiovascular–kidney–metabolic (CKM) syndrome highlights the deep, interconnected health risks of obesity, diabetes, chronic kidney disease, and cardiovascular disease. Learn why integrating comprehensive CKM risk assessment into routine care is critical for providing timely guideline-directed medical therapy and when referrals should be made to support multidisciplinary collaboration.

Released: September 30, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Target Audience

This program is intended for family medicine physicians, nurse practitioners, and physician associates and other primary care healthcare professionals involved in the care of patients with CKM diseases.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients at elevated cardiovascular and kidney risk to support earlier, evidence-based risk stratification strategies in family medicine settings

  • Develop individualized, evidence-based treatment plans that incorporate cardio-renoprotective therapies to reduce CKM-related morbidity and mortality

  • Implement team-based and patient-centered care strategies to improve coordination, optimize adherence, and reduce progression of CKM-related complications

Financial Disclosures

Primary Author

Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP: consultant/advisor/speaker: Abiomed/Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardurion, Cytokinetics, Idorsia, Lilly, Medtronic, Merck, Novo Nordisk, Regeneron, Renovacor, Respicardia/Zoll, Roche, Salubris, Sanofi Aventis, scPharmaceuticals, Vasa, Vifor.

Additional Disclosures

Generative artificial intelligence (AI) tools were used for drafting educational content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.